Financial Ratios HBM Healthcare Investments AG

Equities

HBMN

CH0012627250

Investment Management & Fund Operators

Market Closed - Swiss Exchange Other stock markets 09:00:30 08/05/2026 pm IST			5-day change	1st Jan Change
234.00 ^CHF	0.00%		-0.43%	+3.31%

29/04	SnapMedTech, Inc. acquired connectRN Inc.	CI
07/04	Kavaljer Investmentbolagsfond fell 5.2 percent in March - negative contributions from Ratos, Latour and Svolder	FW

eecbaf6cb6b4b3b81d48847c8.-Kq8lp9NYD1k9LGI2DG9-xCYAZMBDIye5dp37pGU638.jNPw8PUKU3gBxYal7QP3vln1TN5JSbvxo5gSw6DbnCfL9YzD3TgPdirG4A

Published financial data: HBM HEALTHCARE INVESTMENTS AG

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2021	2022	2023	2024	2025
Gain (Loss) on Sale of Investment, Total (Rev)	71Cr	-12Cr	-21Cr	-12Cr	-5.07Cr
Interest And Invest. Income (Rev)	5.9Cr	5Cr	7.15Cr	12Cr	7.3Cr
Other Revenues, Total	-	-	-	-	-
Total Revenues	77Cr	-7.38Cr	-14Cr	29.82L	2.23Cr
Gross Profit	77Cr	-7.38Cr	-14Cr	29.82L	2.23Cr
Selling General & Admin Expenses, Total	92.95L	8L	7L	16.04L	15.86L
Other Operating Expenses	7L	8L	7L	9L	9L
Other Operating Expenses, Total	1Cr	15.31L	14.21L	24.62L	25.03L
Operating Income	76Cr	-7.53Cr	-14Cr	5L	1.98Cr
Interest Expense, Total	-24.72L	-27.17L	-26.49L	-16.97L	-13.26L
Interest And Investment Income	-	-	-	94T	49T
Net Interest Expenses	-24.72L	-27.17L	-26.49L	-16.03L	-12.77L
Currency Exchange Gains (Loss)	-	-	-	-	-
EBT, Excl. Unusual Items	76Cr	-7.8Cr	-15Cr	-10.83L	1.85Cr
EBT, Incl. Unusual Items	76Cr	-7.8Cr	-15Cr	-10.83L	1.85Cr
Earnings From Continuing Operations	76Cr	-7.8Cr	-15Cr	-10.83L	1.85Cr
Net Income to Company	76Cr	-7.8Cr	-15Cr	-10.83L	1.85Cr
Net Income - (IS)	76Cr	-7.8Cr	-15Cr	-10.83L	1.85Cr
Net Income to Common Incl Extra Items	76Cr	-7.8Cr	-15Cr	-10.83L	1.85Cr
Net Income to Common Excl. Extra Items	76Cr	-7.8Cr	-15Cr	-10.83L	1.85Cr
Per Share Items
Net EPS - Basic	108.71	-11.22	-21.03	-0.16	2.72
Basic EPS - Continuing Operations	108.71	-11.22	-21.03	-0.16	2.72
Basic Weighted Average Shares Outstanding	69.57L	69.57L	69.57L	69.32L	68.05L
Net EPS - Diluted	108.71	-11.22	-21.03	-0.16	2.72
Diluted EPS - Continuing Operations	108.71	-11.22	-21.03	-0.16	2.72
Diluted Weighted Average Shares Outstanding	69.57L	69.57L	69.57L	69.32L	68.05L
Normalized Basic EPS	67.94	-7.01	-13.14	-0.1	1.7
Normalized Diluted EPS	67.94	-7.01	-13.14	-0.1	1.7
Dividend Per Share	9.5	9.7	7.5	7.5	7.5
Payout Ratio	-	-	-	-	-
Supplemental Items
EBITA	76Cr	-7.53Cr	-14Cr	5L	1.98Cr
EBIT	76Cr	-7.53Cr	-14Cr	5L	1.98Cr
Total Revenues (As Reported)	77Cr	-7.38Cr	-14Cr	29.82L	2.23Cr
Normalized Net Income	47Cr	-4.88Cr	-9.14Cr	-7L	1.16Cr
Interest on Long-Term Debt	25L	26L	26.49L	13L	13L
Supplemental Operating Expense Items
General and Administrative Expenses	-	-	-	-	-

Fiscal Period: March	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	60.33L	53.88L	57.32L	1.02Cr	24.79L
Short Term Investments	-	-	-	-	-
Total Cash And Short Term Investments	60.33L	53.88L	57.32L	1.02Cr	24.79L
Accounts Receivable, Total	17T	20T	16T	60T	37T
Total Receivables	17T	20T	16T	60T	37T
Total Current Assets	60.5L	54.08L	57.48L	1.03Cr	25.16L
Long-term Investments	225.58Cr	213.2Cr	191.83Cr	179.63Cr	174.56Cr
Other Long-Term Assets, Total	-	-	-	-	-
Total Assets	226.19Cr	213.75Cr	192.4Cr	180.66Cr	174.81Cr
Liabilities
Accrued Expenses, Total	81.54L	-	-	-	-
Current Portion of Long-Term Debt	5Cr	-	5Cr	-	-
Other Current Liabilities	24.71L	20.45L	21.73L	33.14L	31.16L
Total Current Liabilities	6.06Cr	20.45L	5.22Cr	33.14L	31.16L
Long-Term Debt	4.98Cr	15Cr	9.92Cr	9.94Cr	9.96Cr
Total Liabilities	11Cr	15Cr	15Cr	10Cr	10Cr
Common Stock, Total	29Cr	20Cr	14Cr	8.42Cr	3.2Cr
Retained Earnings	171.88Cr	164.08Cr	149.45Cr	149.34Cr	151.19Cr
Treasury Stock	-4L	-4L	-4L	-1.6Cr	-4.18Cr
Comprehensive Income and Other	14Cr	14Cr	14Cr	14Cr	14Cr
Total Common Equity	215.15Cr	198.65Cr	177.27Cr	170.39Cr	164.54Cr
Total Equity	215.15Cr	198.65Cr	177.27Cr	170.39Cr	164.54Cr
Total Liabilities And Equity	226.19Cr	213.75Cr	192.4Cr	180.66Cr	174.81Cr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	69.57L	69.57L	69.57L	68.68L	67.32L
ECS Total Common Shares Outstanding	69.57L	69.57L	69.57L	68.68L	67.32L
Book Value / Share	309.25	285.53	254.8	248.1	244.41
Tangible Book Value	215.15Cr	198.65Cr	177.27Cr	170.39Cr	164.54Cr
Tangible Book Value Per Share	309.25	285.53	254.8	248.1	244.41
Total Debt	9.98Cr	15Cr	15Cr	9.94Cr	9.96Cr
Net Debt	9.37Cr	14Cr	14Cr	8.92Cr	9.71Cr
Equity Method Investments, Total	-	-	-	-	-
Account Code - Inventory Valuation	3	3	3	3	3

Fiscal Period: March	2021	2022	2023	2024	2025
Net Income	76Cr	-7.8Cr	-15Cr	-10.83L	1.85Cr
Other Operating Activities, Total	-76Cr	6.78Cr	15Cr	-6L	-2.09Cr
Cash from Operations	-32.26L	-1.02Cr	-12.88L	-17.05L	-23.61L
Investment in Marketable and Equity Securities, Total	-	-	-	-	-
Other Investing Activities, Total	5.9Cr	5Cr	7.15Cr	12Cr	7.3Cr
Cash from Investing	5.9Cr	5Cr	7.15Cr	12Cr	7.3Cr
Long-Term Debt Issued, Total	-	9.89Cr	-	-	-
Total Debt Issued	-	9.89Cr	-	-	-
Long-Term Debt Repaid, Total	-	-5Cr	-	-5Cr	-
Total Debt Repaid	-	-5Cr	-	-5Cr	-
Issuance of Common Stock	-	-	-	-	-
Repurchase of Common Stock	-5.36Cr	-8.7Cr	-6.75Cr	-6.65Cr	-7.73Cr
Common Dividends Paid	-	-	-	-	-
Common & Preferred Stock Dividends Paid	-	-	-	-	-
Other Financing Activities, Total	-22.67L	-23.87L	-23.84L	-23.02L	-10.94L
Cash from Financing	-5.58Cr	-4.04Cr	-6.99Cr	-12Cr	-7.84Cr
Foreign Exchange Rate Adjustments	-	-	-	-	-
Net Change in Cash	-63T	-6L	3L	44.95L	-77.48L
Supplemental Items
Cash Interest Paid	22.67L	23.87L	23.84L	23.02L	10.94L
Levered Free Cash Flow	48Cr	-5.74Cr	-9.13Cr	4L	1.14Cr
Unlevered Free Cash Flow	48Cr	-5.57Cr	-8.97Cr	14.22L	1.22Cr
Change In Net Working Capital	-68.11L	85.83L	-1L	-10.97L	2L
Net Debt Issued / Repaid	-	4.89Cr	-	-5Cr	-

Fiscal Period: March	2021	2022	2023	2024	2025
Profitability
Return on Assets	24.87	-2.14	-4.42	0.02	0.7
Return on Total Capital	24.96	-2.15	-4.43	0.02	0.7
Return On Equity %	42.01	-3.77	-7.78	-0.06	1.11
Return on Common Equity	42.01	-3.77	-7.78	-0.06	1.11
Margin Analysis
Gross Profit Margin %	100	100	100	100	100
SG&A Margin	1.21	-1.02	-0.5	53.79	7.1
EBITA Margin %	98.69	102.08	101	17.44	88.79
EBIT Margin %	98.69	102.08	101	17.44	88.79
Income From Continuing Operations Margin %	98.37	105.76	102.86	-36.32	83.07
Net Income Margin %	98.37	105.76	102.86	-36.32	83.07
Net Avail. For Common Margin %	98.37	105.76	102.86	-36.32	83.07
Normalized Net Income Margin	61.48	66.1	64.29	-22.7	51.92
Levered Free Cash Flow Margin	62.37	77.73	64.2	12.12	51
Unlevered Free Cash Flow Margin	62.57	75.43	63.03	47.69	54.71
Asset Turnover
Asset Turnover	0.4	-0.03	-0.07	0	0.01
Short Term Liquidity
Current Ratio	0.1	2.64	0.11	3.1	0.81
Quick Ratio	0.1	2.64	0.11	3.1	0.81
Operating Cash Flow to Current Liabilities	-0.05	-4.99	-0.02	-0.51	-0.76
Long Term Solvency
Total Debt/Equity	4.64	7.5	8.42	5.83	6.05
Total Debt / Total Capital	4.43	6.97	7.76	5.51	5.71
LT Debt/Equity	2.31	7.5	5.6	5.83	6.05
Long-Term Debt / Total Capital	2.21	6.97	5.16	5.51	5.71
Total Liabilities / Total Assets	4.88	7.06	7.87	5.68	5.87
EBIT / Interest Expense	306.93	-27.72	-54.24	0.31	14.95
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	307.57	-109.6	92.79	-102.1	648.56
Gross Profit, 1 Yr. Growth %	307.57	-109.6	92.79	-102.1	648.56
EBITA, 1 Yr. Growth %	309.84	-109.93	90.76	-100.36	3.71T
EBIT, 1 Yr. Growth %	309.84	-109.93	90.76	-100.36	3.71T
Earnings From Cont. Operations, 1 Yr. Growth %	313.95	-110.32	87.51	-99.26	-1.81T
Net Income, 1 Yr. Growth %	313.95	-110.32	87.51	-99.26	-1.81T
Normalized Net Income, 1 Yr. Growth %	313.95	-110.32	87.51	-99.26	-1.81T
Diluted EPS Before Extra, 1 Yr. Growth %	313.95	-110.32	87.51	-99.26	-1.84T
Accounts Receivable, 1 Yr. Growth %	-37.04	17.65	-20	275	-38.33
Total Assets, 1 Yr. Growth %	45.72	-5.5	-9.98	-6.11	-3.24
Tangible Book Value, 1 Yr. Growth %	48.5	-7.67	-10.76	-3.88	-3.43
Common Equity, 1 Yr. Growth %	48.5	-7.67	-10.76	-3.88	-3.43
Cash From Operations, 1 Yr. Growth %	-22.41	216.09	-87.37	32.38	38.48
Levered Free Cash Flow, 1 Yr. Growth %	322.38	-111.96	59.22	-100.4	3.05T
Unlevered Free Cash Flow, 1 Yr. Growth %	318.14	-111.57	61.1	-101.59	758.78
Dividend Per Share, 1 Yr. Growth %	23.38	2.11	-22.68	0	0
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	88.87	-37.46	-56.98	-79.9	-60.39
Gross Profit, 2 Yr. CAGR %	88.87	-37.46	-56.98	-79.9	-60.39
EBITA, 2 Yr. CAGR %	89.4	-36.22	-56.49	-91.69	-62.86
EBIT, 2 Yr. CAGR %	89.4	-36.22	-56.49	-91.69	-62.86
Earnings From Cont. Operations, 2 Yr. CAGR %	90.19	-34.65	-56.01	-88.22	-64.4
Net Income, 2 Yr. CAGR %	90.19	-34.65	-56.01	-88.22	-64.4
Normalized Net Income, 2 Yr. CAGR %	90.19	-34.65	-56.01	-88.22	-64.4
Diluted EPS Before Extra, 2 Yr. CAGR %	90.19	-34.65	-56.01	-88.2	-64.01
Accounts Receivable, 2 Yr. CAGR %	-19.14	-13.93	-2.99	73.21	52.07
Total Assets, 2 Yr. CAGR %	26.11	17.35	-7.77	-8.07	-4.68
Tangible Book Value, 2 Yr. CAGR %	27.75	17.1	-9.23	-7.39	-3.66
Common Equity, 2 Yr. CAGR %	27.75	17.1	-9.23	-7.39	-3.66
Cash From Operations, 2 Yr. CAGR %	6.35	56.6	-36.81	-59.11	35.39
Levered Free Cash Flow, 2 Yr. CAGR %	90.72	-28.92	-56.36	-92.06	-64.69
Unlevered Free Cash Flow, 2 Yr. CAGR %	89.94	-30.45	-56.83	-84.02	-63.09
Dividend Per Share, 2 Yr. CAGR %	12.55	12.24	-11.15	-12.07	0
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	85.17	-30.04	-8.98	-84.29	-32.87
Gross Profit, 3 Yr. CAGR %	85.17	-30.04	-8.98	-84.29	-32.87
EBITA, 3 Yr. CAGR %	85.79	-29.12	-8.1	-91.18	-35.92
EBIT, 3 Yr. CAGR %	85.79	-29.12	-8.1	-91.18	-35.92
Earnings From Cont. Operations, 3 Yr. CAGR %	86.88	-28	-7.13	-88.73	-38.06
Net Income, 3 Yr. CAGR %	86.88	-28	-7.13	-88.73	-38.06
Normalized Net Income, 3 Yr. CAGR %	86.88	-28	-7.13	-88.73	-38.06
Diluted EPS Before Extra, 3 Yr. CAGR %	87.27	-28	-7.13	-88.72	-37.6
Accounts Receivable, 3 Yr. CAGR %	-22.84	-8.37	-16.01	52.25	22.76
Total Assets, 3 Yr. CAGR %	21.52	14.55	7.42	-7.22	-6.48
Tangible Book Value, 3 Yr. CAGR %	22.94	14.65	6.96	-7.48	-6.09
Common Equity, 3 Yr. CAGR %	22.94	14.65	6.96	-7.48	-6.09
Cash From Operations, 3 Yr. CAGR %	0.81	52.91	-32.34	-19.15	-38.59
Levered Free Cash Flow, 3 Yr. CAGR %	88.47	-24.22	-7	-90.9	-41.67
Unlevered Free Cash Flow, 3 Yr. CAGR %	87.36	-25.27	-7.97	-85.65	-39.68
Dividend Per Share, 3 Yr. CAGR %	10.72	8.95	-0.87	-7.58	-8.22
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	95.07	-12.32	3.27	-57.52	-34.74
Gross Profit, 5 Yr. CAGR %	95.07	-12.32	3.27	-57.52	-34.74
EBITA, 5 Yr. CAGR %	97.03	-11.56	3.96	-69.93	-36.04
EBIT, 5 Yr. CAGR %	97.03	-11.56	3.96	-69.93	-36.04
Earnings From Cont. Operations, 5 Yr. CAGR %	99.71	-10.62	4.78	-65.1	-36.72
Net Income, 5 Yr. CAGR %	99.71	-10.62	4.78	-65.1	-36.72
Normalized Net Income, 5 Yr. CAGR %	99.71	-10.62	4.78	-65.1	-36.72
Diluted EPS Before Extra, 5 Yr. CAGR %	103.55	-9.97	4.91	-65.07	-36.44
Accounts Receivable, 5 Yr. CAGR %	-20.64	-17.07	-15.44	18.2	6.5
Total Assets, 5 Yr. CAGR %	14.75	12.26	8.83	4.9	2.41
Tangible Book Value, 5 Yr. CAGR %	15.76	12.64	8.89	5.27	2.58
Common Equity, 5 Yr. CAGR %	15.76	12.64	8.89	5.27	2.58
Cash From Operations, 5 Yr. CAGR %	-7.56	42.85	-16.37	-9.78	-10.7
Levered Free Cash Flow, 5 Yr. CAGR %	37.2	-7.85	4.98	-69.27	-36.87
Unlevered Free Cash Flow, 5 Yr. CAGR %	37.59	-8.72	4.16	-59.67	-36.15
Dividend Per Share, 5 Yr. CAGR %	11.55	10.83	1.39	0	-0.52